期刊
NATURE REVIEWS CANCER
卷 20, 期 1, 页码 12-25出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/s41568-019-0224-7
关键词
-
类别
资金
- National Institutes of Health [R01-NS099463, P50-CA190991, P30-CA14236, P01-CA225622, R01-CA235612, U01-NS090284, R01-NS085412, R01-CA175517]
Gliomas, the most common malignant primary brain tumours, remain universally lethal. Yet, seminal discoveries in the past 5 years have clarified the anatomy, genetics and function of the immune system within the central nervous system (CNS) and altered the paradigm for successful immunotherapy. The impact of standard therapies on the response to immunotherapy is now better understood, as well. This new knowledge has implications for a broad range of tumours that develop within the CNS. Nevertheless, the requirements for successful therapy remain effective delivery and target specificity, while the dramatic heterogeneity of malignant gliomas at the genetic and immunological levels remains a profound challenge.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据